Maher, Toby M <br/><br/>
Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension.  [electronic resource] 

 -  Journal of managed care & specialty pharmacy  Mar 2017 
 - S3-S4 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2376-1032 
<br/><br/><label>Standard No.: </label>10.18553/jmcp.2017.23.3-b.s3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Humans<br/>Hypertension, Pulmonary--diagnosis<br/>Idiopathic Pulmonary Fibrosis--diagnosis<br/>Indoles--therapeutic use<br/>Phosphodiesterase 5 Inhibitors--therapeutic use<br/>Pyridones--therapeutic use<br/>Survival Rate--trends